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OBJECTIVES: To assess the association between Staphy-
lococcus aureus (S. aureus) blood stream infections (BSIs)
and morbidity and mortality in older adults.
DESIGN: Retrospective review.
SETTING: Veterans Affairs Ann Arbor Healthcare Sys-
tem.
PARTICIPANTS: All patients with S. aureus BSI during
2004/05.
MEASUREMENTS: Outcomes included in-hospital and
6-month mortality, as well as need for subacute care.
RESULTS: Sixty-eight patients with S. aureus BSI were
identified (mean age 63.5  13.0). Outcomes of interest in-
cluded in-hospital mortality (19.1%), 6-month mortality
(33.8%), and need for subacute care (65.4%). Univariate
analysis identified several predictors of death, including
older age, chronic renal insufficiency, catheter-related in-
fection, Charlson weighted index of comorbidity score, and
infection with methicillin-resistant S. aureus (MRSA). Mul-
tivariable analysis demonstrated that older age (odds ratio
(OR) 5 1.1, Po.01), chronic renal insufficiency (OR 5
16.6, P 5.01), and MRSA infection (OR 5 5.1, P 5.03)
were independently associated with 6-month mortality.
These results suggest that, for every decade increase in age,
the odds of death within 6 months of S. aureus BSI doubles
(OR 5 1.1). Chronic renal insufficiency was also indepen-
dently associated with in-hospital mortality. Of the previ-
ously community-dwelling patients (n 5 50), 41 survived
hospitalization, of whom 22 (53.7%) required subacute
care after discharge.
CONCLUSION: Better understanding of the epidemiolo-
gy of S. aureus BSI in older patients and validation of risk
factors for poor functional outcomes and death should
be the focus of future prospective studies. J Am Geriatr Soc
56:1485–1489, 2008.
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Despite vast improvements in medical care, adjustedrates of hospitalization for bloodstream infection (BSI)
continue to climb in older adults.1,2 In recent years, death
rates due to BSI have risen two to three times in persons
aged 65 and older, seven times in those aged 75, and 20
times in those aged 85 and older.2 In some series, overall
BSI-associated mortality has been reported to be greater
than 50% in older adults, with the highest mortality rates
associated with Staphylococcus aureus (S. aureus) infec-
tion.1–14
S. aureus BSIs are among the most morbid of common
infections, and the incidence continues to increase at a
higher rate than BSI caused by other organisms.15–18 The
epidemiology of S. aureus BSI in elderly people differs from
that of younger patients in that older adults are more likely
to have catheter- and device-related infections and less
likely to have infections related to intravenous drug
use.3,13,18 Older adults also have a higher incidence of meth-
icillin-resistant strains, reflecting the higher rates of
healthcare-associated acquisition.3,4,18 Associated risk fac-
tors for development of S. aureus BSI include a higher in-
cidence of comorbid illness, such as congestive heart failure,
chronic pulmonary disease, hypertension, and diabetes
mellitus. Risk factors for death include methicillin resis-
tance, age, renal failure, length of mechanical ventilation,
and presence of devices.3,15–18
In the general population, recent studies of S. aureus
BSI demonstrate overall 30-day mortality rates of 30% de-
spite appropriate antimicrobial therapy.16 Few studies spe-
cifically assess prognosis and outcomes from infection in
older adults.19 Despite high (and increasing) incidence and
substantial overall mortality, S. aureus BSI remains under-
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studied, especially in elderly people. Although mortality is
higher in older adults with S. aureus BSI, the effect of in-
fection on physical and cognitive functional status and
long-term care needs is not known. It is likely that older
adults not only suffer higher mortality from S. aureus BSI,
but also experience longer recovery times and more-persis-
tent functional impairment than younger adults, leading to
prolonged hospitalization, need for subacute care, and
higher healthcare costs.
To better understand the relationship between older
age and clinical outcomes and to identify other variables of
interest, a retrospective study was conducted of all com-
munity- and healthcare-associated S. aureus BSI in patients
admitted to the Veterans Affairs (VA)Ann Arbor Healthcare
System during 2004/05. In addition to mortality (in-hospi-
tal and 6-month), the need for subacute care was also as-
sessed as a marker of functional status, and available
Minimum Data Set (MDS) records were examined for in-
formation on activities of daily living (ADLs) and mobility.
The findings are presented in this article.
METHODS
Overall Research Design
The VA Ann Arbor Healthcare System (AAVA) is a 150-bed
tertiary care facility closely affiliated with the University of
Michigan Health System. S. aureus BSI was defined as any
blood culture positive for S. aureus with an appropriate
clinical presentation. Baseline demographic data, clinical
conditions, and characteristics of the BSI were recorded. In
addition, comorbidity was measured using the Charlson
weighted index of comorbidity (WIC).20 Outcomes of
interest included in-hospital mortality and death within
6 months of the development of the BSI. Need for subacute
care after discharge in patients who survived hospitaliza-
tion was also recorded as a measure of diminished
functional status. The admitting service generally deter-
mined the need for subacute care in consultation with the
divisions of geriatric medicine and infectious diseases.
Patients requiring subacute care were admitted to the
AAVA’s attached extended care center (ECC) or discharged
to a community nursing center. The institutional review
board of the AAVA approved this study.
Data Analysis
Univariate analysis using simple logistic regression identi-
fied risk factors for death in patients with S. aureus BSI. A
two-tailed P-value less than .05 was considered statistically
significant. Crude odds ratios (ORs) and 95% confidence
intervals (CIs) were calculated. Age was represented in a
continuous fashion in the model with 1 year serving as the
unit of measure. Variables that were significant at a P-value
of .20 in univariate analysis and variables that had a priori
clinical significance were then analyzed using multivariable
logistic regression modeling. All statistical analysis was
performed using SAS 9.1 (SAS Institute Inc., Cary, NC).
RESULTS
Patient characteristics are listed in Table 1. Sixty-eight pa-
tients with a S. aureus BSI with a mean age of 63.5  13
(range 20–89) were identified; all but one were male
(98.5%). (Figure 1) Common medical comorbidities of pa-
tients were hypertension (70.6%), diabetes mellitus (50%),
and coronary artery disease (42.6%). The most common
sources of S. aureus infection were catheter related
(32.2%), wound related (26.5%), and endocarditis
Table 1. Characteristics of 68 Patients with Staphylo-
coccus aureus Blood Stream Infections
Characteristic Value
Age, mean  SD 63.5  13.2
Male, n (%) 67 (98.5)
Comorbidities, n (%)
Hypertension 48 (70.6)
Coronary artery disease 29 (42.6)
Congestive heart failure 15 (22.1)
Peripheral vascular disease 22 (32.3)
Diabetes mellitus 34 (50)
End-stage renal disease 9 (13.2)
Chronic renal insufficiency 8 (11.8)
Pulmonary disease 18 (26.5)
Cirrhosis 10 (14.7)
Psychiatric illness 15 (22.1)
Malignancy 15 (22.1)
Stroke 10 (14.7)
Recent hospitalization, n (%)w 22 (32.3)
Need for enteral feeding, n (%) 6 (8.8)
Charlson weighted index score, mean  SD 5.6  2.5




Respiratory tract 11 (16.2)
Unknown source 11 (16.2)
Osteoarticular 6 (8.8)
Genitourinary 2 (3.0)
Baseline serum creatinine of 2 mg/dL.
wHospital admission within previous 30 days.


















Figure 1. Age distribution of patients with Staphylococcus
aureus bloodstream infection according to decade (N 5 68).
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(20.6%). Thirty-six episodes of BSI (52.9%) were second-
ary to MRSA, the remaining 32 (47.1%) were secondary to
methicillin-sensitive S. aureus (MSSA).
Of the 68 patients, 50 lived in the community before
admission, either alone (n 5 11) or with family members
(n 5 39). Another 16 patients were admitted from an ex-
tended care setting, either chronic or subacute care. The
remaining two patients were transferred from another hos-
pital, although both lived in the community before admis-
sion to the outside hospital.
Thirteen of the 68 patients (19%) died before discharge
during the initial hospitalization. An additional 10 patients
died within 6 months of developing the S. aureus BSI (Table
2). Of the 55 patients who survived hospitalization, 36
(65.4%) required admission to an extended care facility.
Twenty-six of the 36 extended care patients received sub-
acute care at the VA’s ECC. Primary reasons for subacute
care included impaired mobility and nutrition, wound care,
and need for parenteral antimicrobial therapy. The ECC
does not offer long-term care. The AAVA has a well-estab-
lished home antimicrobial program,21 so few patients were
sent to subacute care just to complete a course of therapy.
Of the previously community-dwelling patients (n 5 50), 41
survived hospitalization, of whom 22 (53.7%) required
subacute care after discharge. Not surprisingly, older age
predicted need for subacute care in previously independent
patients (OR 5 1.05, P 5.04).
MDS data were available for 26 of the 68 (38%) pa-
tients. Nine of the 26 were independent or needed minimal
assistance with ADLs and mobility. The remaining 17
(65.4%) patients required a minimum of assistance with
two or more ADLs, bed mobility, or both from one person.
Of the 17, 12 (70.5%) were initially admitted from the
community, all living independently alone or with family.
The other five patients were admitted from a subacute or
skilled care setting.
Univariate analysis identified several factors associated
with mortality (in-hospital and 6-month) including age,
chronic renal insufficiency (defined as serum creatinine
2 mg/dL), catheter-related infection, Charlson WIC score,
and MRSA infection (Table 2). Of these characteristics,
three remained independently associated with 6-month
mortality based on multivariate analysis: age (OR 5 1.1,
Po.01), chronic renal insufficiency (OR 5 16.6, P 5.01),
and MRSA infection (OR 5 5.1, P 5.03) (Table 3). The
adjusted OR for age suggests that, for every 10 years in-
crease in age, the odds of dying within 6 months of S. aureus
BSI doubles. Chronic renal insufficiency was also indepen-
dently associated with in-hospital mortality (OR 5 7.0,
P 5.03); age demonstrated borderline significance for in-
hospital mortality (OR 5 1.05, P 5.08).
DISCUSSION
The preceding results offer further evidence that older age is
an independent predictor of mortality associated with S.
aureus BSI. These results suggest that, for every 10 years
increase in age, the odds of dying within 6 months of S.
aureus BSI doubles (OR 5 1.1). In addition to significant
mortality, S. aureus BSI is perhaps associated with a decline
in functional status in older adults. Specifically, the need for
subacute care after discharge was seen in two-thirds of pa-
tients who survived hospitalization. Even in those who lived
independently in the community before admission, more
than half required care after discharge. Age predicted the
need for such care in previously independent patients
(OR 5 1.05, P 5.04), as well as in the overall study pop-
ulation. Although there are multiple reasons why patients
require subacute care posthospitalization, including anti-
microbial administration and wound care, the limited MDS
records available suggested significant impairments in mo-
Table 2. Univariate Analysis of the Effect of Patient Characteristics on In-Hospital and 6-Month Mortality from


















OR (95% CI) P-Value
Patient characteristics
Age, mean  SD 62.3  14 68.9  8 1.05 (1.0–1.1) .10 60.6  14 69.4  9 1.07 (1.0–1.1) .01
Charlson index, mean  SD 5.2  2.5 7.1  2.1 1.38 (1.0–1.8) .02 4.9  2.2 6.9  2.5 1.5 (1.1–1.9) o.001
Diabetes mellitus, n (%) 26 (47.2) 8 (61.5) 1.8 (0.5–6.1) .35 21 (46.7) 13 (56.5) 1.5 (0.5–4.1) .44
Peripheral vascular disease, n (%) 16 (29.1) 6 (46.2) 2.1 (0.6–7.2) .23 13 (28.9) 9 (39.1) 1.6 (0.5–4.5) .40
Chronic renal insufficiency, n (%) 4 (7.2) 4 (30.8) 5.7 (1.2–27) .05 2 (4.4) 6 (26.1) 7.5 (1.4–41) .02
End-stage renal disease, n (%) 7 (12.7) 2 (15.4) 1.3 (0.2–6.8) .64 4 (8.8) 5 (21.7) 2.8 (0.7–12) .25
Enteral feeding, n (%) 4 (7.2) 2 (15.4) 2.3 (0.4–14) .99 2 (4.4) 4 (17.4) 4.5 (0.7–27) .20
Source of infection, n (%)
Catheter related 16 (29.1) 6 (46.2) 2.1 (0.6–7.2) .24 11(24.4) 11 (47.8) 2.8 (1.0–8.2) .05
Wound related 15 (27.2) 3 (23.1) 0.8 (0.2–3.3) .99 13 (28.9) 5 (21.7) 0.7 (0.2–2.2) .74
Endocarditis 13 (23.6) 1 (7.7) 0.3 (0.03–2.3) .38 12 (26.7) 2 (8.7) 0.3 (0.1–1.3) .12
Unknown 7 (12.7) 4 (30.8) 3.1 (0.7–12.6) .99 5 (11.1) 6 (26.1) 2.8 (0.8–10.5) .22
Methicillin-resistant
Staphylococcus aureus
27 (49.1) 9 (69.2) 2.3 (0.6–8.5) .30 19 (42.2) 17 (73.9) 3.8 (1.3–11.7) .01
Odds ratio (OR) for age reported for 1-year unit.
CI 5 confidence interval.
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bility and cognitive function in patients who previously
lived independently.
Before planned prospective studies related to func-
tional status and S. aureus infection were begun, this pilot
study was performed to identify potential predictors of
mortality. Although its retrospective design, a small sample
size, and incomplete functional assessments limited the
present study, the results suggest an association between age
and functional decline and between age and mortality. This
study was conducted at a VA hospital, which serves a pop-
ulation that tends to be overwhelmingly male and relatively
young, with high rates of comorbid illnesses. Although
98% of the study patients were male, these preliminary
results are generalizable, given that there is no evidence in
the literature that outcome for S. aureus BSI varies accord-
ing to sex.
The difference between in-hospital and 6-month mor-
tality and the possible effect of age is intriguing. The results
suggest that, even if an older adult survives hospitalization
for a S. aureus BSI, a significant risk of debility at discharge
and death at 6 months remains. This potential difference
offers further support for future studies to assess functional
status and the effect of rehabilitation on outcomes from S.
aureus BSI. Better understanding of the epidemiology of S.
aureus BSI in older patients, as well as validation of risk
factors for poor functional outcomes and death, can also
help direct future studies of focused interventions such as
decolonization, antimicrobial-coated devices, and even vac-
cines.22–24
Assessing who among elderly people develops S. aureus
BSI, who is likely to survive, and what effect is seen on
functional status will be important in developing prognostic
indices and new treatment algorithms.19,25
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